Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 13/20 | 0.37 |
| ▸ | ENPEP | Q07075 | 3/20 | 0.36 |
| ▸ | MME | P08473 | 1/20 | 0.36 |
| ▸ | DPP4 | P27487 | 1/20 | 0.35 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.35 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.35 |
| ▸ | BACE2 | Q9Y5Z0 | 3/20 | 0.34 |
| ▸ | BMP1 | P13497 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | CTSD | P07339 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30782660 | 0.94 | BACE1 (0.39) | BACE1ENPEPMMEDPP4DPP8 | |
| SCHEMBL29590459 | 0.92 | MME (0.38) | BACE1MMEDPP4DPP8DPP9 | |
| SCHEMBL31482979 | 0.92 | MME (0.38) | BACE1MMEDPP4DPP8DPP9 | |
| SCHEMBL29630607 | 0.92 | MME (0.38) | BACE1MMEDPP4DPP8DPP9 | |
| SCHEMBL5970335 | 0.91 | DPP4 (0.39) | BACE1MMEDPP4DPP8DPP9 | |
| SCHEMBL2780884 | 0.91 | DPP4 (0.39) | BACE1MMEDPP4DPP8DPP9 | |
| SCHEMBL30436348 | 0.91 | BACE1 (0.40) | BACE1MMEBACE2BMP1KMT2A | |
| SCHEMBL29630385 | 0.90 | BACE1 (0.39) | BACE1MMEDPP4DPP8DPP9 | |
| SCHEMBL29630656 | 0.90 | DPP4 (0.35) | BACE1MMEDPP4DPP8DPP9 | |
| SCHEMBL30477912 | 0.89 | MME (0.40) | BACE1ENPEPMME |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11628202-B2 | Methods of reducing the need for surgery in patients suffering from benign prostatic hyperplasia | NYMOX CORPORATION (CA) | 2023-04-18 | — | — | US | disclosed |